Urinary indoxyl sulfate in children: age-related decline and its association with Bacteroidota in the gut microbiota
Related Experiment Video
Updated: Jul 3, 2026

Oral Biofilm Sampling for Microbiome Analysis in Healthy Children
Published on: December 31, 2017
Yuko Akagawa1, Shohei Akagawa1, Shoji Tsuji1
1Department of Pediatrics, Kansai Medical University, 2-5-1 Shinmachi, Hirakata, Osaka 573-1010, Japan.
Insights
Urinary indoxyl sulfate (IS) levels in healthy children decrease with age. After adjusting for age, IS/creatinine ratios can serve as a non-invasive marker for specific gut bacteria, particularly Bacteroidota.
Area of Science:
- Pediatric Gastroenterology
- Microbiome Research
- Uremic Toxin Analysis
Background:
- Urinary indoxyl sulfate (IS), a gut microbiota-derived uremic toxin, is linked to adult gut microbiota and elevated in children with autism spectrum disorder.
- The age-related trajectory and gut microbiota associations of IS in healthy children are not well understood.
Purpose of the Study:
- To determine age-related changes in urinary IS in healthy children.
- To assess the potential of urinary IS as a surrogate marker for pediatric gut microbiota composition.
Main Methods:
- Measured urinary IS/creatinine (Cr) ratios in 102 healthy Japanese children (5 months to 12 years).
- Analyzed fecal gut microbiota composition using 16S rRNA gene sequencing.
- Developed an age-adjustment model to correct for age-dependent IS/Cr variations and assessed correlations with microbiota.
Main Results:
- The unadjusted IS/Cr ratio showed a significant negative correlation with age, declining markedly in early childhood and stabilizing around age 5.
- Age adjustment removed the correlation between IS/Cr ratio and age.
- After age adjustment, significant positive correlations were found between the IS/Cr ratio and the abundance of Bacteroidota phylum and *Bacteroides* genus.
Conclusions:
- Correcting for age-dependent variations in urinary IS/Cr ratios is essential.
- The age-adjusted IS/Cr ratio shows potential as a non-invasive surrogate marker for Bacteroidota abundance, particularly the *Bacteroides* genus, in the pediatric gut microbiota.
Abstract:
Urinary indoxyl sulfate (IS), a gut microbiota-derived uremic toxin, is associated with the adult gut microbiota and is elevated in children with autism spectrum disorder. However, its age-related trajectory and association with microbiota in healthy children remain uncharacterized. Therefore, we aimed to elucidate age-related changes in urinary IS in healthy children and to investigate the potential utility of urinary IS as a surrogate marker for their gut microbiota. We measured urinary IS/creatinine (Cr) ratios and analyzed the fecal gut microbiota composition (16S rRNA gene sequencing) in 102 healthy Japanese children aged 5 months to 12 years. Associations were assessed using Spearman's correlation. An empirical age-adjustment model (inverse proportional) was developed to derive an age-adjusted IS/Cr ratio (actual/predicted), thereby removing the strong age dependence before re-evaluating correlations with gut microbiota. The unadjusted IS/Cr ratio showed a strong negative correlation with age (rs=-0.47, p<0.001) and declined markedly during early childhood, stabilizing at approximately 5 years. Weak correlations with microbiota metrics were observed before adjustment; however, the age-adjusted IS/Cr ratio showed no correlation with age (rs=-0.03, p=0.768). Notably, age adjustment revealed significant positive correlations between the IS/Cr ratio and the phylum Bacteroidota (rs=0.26, p=0.008) and strengthened the correlation with the genus Bacteroides (rs=0.31, p=0.002), associations that were not apparent before adjustment. Correcting for this age-dependent variation is crucial, after which the IS/Cr ratio can serve as a potential non-invasive surrogate marker reflecting the abundance of Bacteroidota, particularly the genus Bacteroides, in the pediatric gut microbiota.
Related Concept Videos
Microbiota of the Urogenital Tract
Development of Human Microbiota
Dysbiosis of the Gut Microbiota
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Microbiota Modulation by Antibiotics
Urinary Tract Infection II: Pathophysiology